You are here: Industry Insights > Cancer treatment

News List

Inventory of New Drug Targets in 2023 roger
May 21, 2024
In 2023, 49 new drugs received their first approval in the United States, the European Union, and Japan.
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care B3C newswire
November 06, 2023
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK).
A Breakthrough in Cancer Treatment: Soundny Presents a New Drug-based Alternative in Fight Against Cancer prnasia
July 07, 2020
Hubei Soundny Biotechnology ("Soundny" or the "Company"), a leading biotechnology company dedicated to developing cancer treatments, has announced the publication of its latest findings on cholangiocarcinoma in Nature Biomedical Engineering, a Nature publ
POINT Biopharma to Launch First US Manufacturing Facility contractpharma
June 03, 2020
Next-gen oncology company plans long-term manufacturing growth, 100+ high-wage jobs in Indianapolis.
Antikor forms alliance with Essex Bio-Investment for cancer treatment pharmaceutical-technology
August 06, 2019
Antikor Biopharma has entered into a strategic alliance with Essex Bio-Technology’s wholly-owned subsidiary Essex Bio-Investment in Fragment-Drug Conjugates (FDC) for cancer treatment.
Eric Lefkofksy's Bloomberg Interview Reveals Integrated Approach to Cancer Treatment biospectrumasia
April 03, 2019
He created the technology company after discovering the technology available to physicians is not up to the standards of many industries.
BioInvent developes Anti-TNFR2 programme for cancer treatment biospectrumasia
March 23, 2019
Using the n-CoDeR® & F.I.R.S.T.™ platforms, the company has generated a broad panel of highly specific anti-TNFR2 antibodies
Flatiron Health expands real-world cancer data collaboration with FDA fiercebiotech
February 27, 2019
The FDA has renewed and expanded its real-world cancer data collaboration with Flatiron Health for another two years, to continue its work into the validation of related clinical endpoints and development of real-world control arms....
Outcome-based payment system could expedite cancer treatment pharmaceutical-technology
February 26, 2019
Commissioned in alliance with the Greater Manchester Health and Social Care Partnership, the report suggests that payment for cancer drugs should be adjusted based on how well they work in practice.....
Lunar New Year focuses on traditional chinese medicine for cancer treatment biospectrumasia
February 11, 2019
Research reveals nearly half of Singaporeans combine potentially dangerous cocktail of Chinese and Western medicine during cancer treatment

Previous page 1 2 3 Next page